Regions Bank, a member of the S&P 500 with $161 billion in assets, is leveraging its financial footprint to address the systemic health challenges facing the Southern United States. This commitment takes the form of a historic $2.5 million pledge to the University of Mississippi Medical Center,
Even after adjusting for age and prior therapy lines, metaplastic histology remains a clear indicator of a poor response to the Trop-2-directed antibody-drug conjugate sacituzumab govitecan. This finding, derived from a comprehensive retrospective analysis at the Massachusetts General Hospital
For years, surgeons have treated the neck primarily as a structural corridor or a gateway for life-saving cancer interventions, unaware that this narrow passage also functions as the brain's essential metabolic exhaust pipe. A groundbreaking study from Weill Cornell Medicine has revealed that
The discovery of a germline mutation in a prostate cancer patient facilitates cascade testing for family members who may be at risk for breast, pancreatic, or ovarian cancers. This clinical reality highlights the expanding role of genetic identification as a cornerstone of modern oncology, moving
The appointment of industry veterans from Bristol Myers Squibb and Iovance Biotherapeutics highlights a major transition toward clinical-stage operations for cell therapy developers. This leadership influx comes at a pivotal moment for Link Cell Therapies as it progresses into the Phase I clinical
A multi-layered screening strategy combining mammography and ultrasound offers the highest probability of catching treatable cancers at their most localized and manageable stage. As the landscape of preventive medicine continues to evolve in 2026, healthcare professionals are increasingly
